Search Results for keywords:"National Institutes of Health"

The National Institutes of Health has announced a change in the previously scheduled meeting for the Oncology 2—Translational Clinical Integrated Review Group. The meeting will take place from May 1 to May 2, 2025, at their Rockledge Drive location in Bethesda, Maryland. This amendment updates the contact for the Scientific Review Officer, replacing Lawrence Ka-Yun Ng with Victor Panchenko, Ph.D. The meeting is closed to the public.

The National Institute on Aging announced a closed meeting of the Special Emphasis Panel for reviewing grant applications. This meeting will occur on January 31, 2025, from 10:30 a.m. to 1:00 p.m., and will be conducted virtually. It will be closed to the public to protect sensitive information like confidential trade secrets and personal data related to the grant applications. For further details, Dr. Bita Nakhai can be contacted at the information provided.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development is holding a closed virtual meeting on April 3-4, 2025, from 9:00 a.m. to 4:00 p.m. The meeting will focus on reviewing and evaluating grant applications related to the Women's Reproductive Health Research (WRHR) Program. This session will be private to protect sensitive information, like trade secrets and personal details related to grant applications. The contact person for more information is Dr. Mei Qin.

The National Cancer Advisory Board will hold a virtual meeting on February 13, 2025, which is open to the public except for a portion that involves confidential discussions about grant applications. The meeting can be accessed online through the NIH Videocast link. It will cover subcommittee meetings, reports, presentations, and board business, with a closed session to evaluate grant applications. Those interested can find more information or submit comments through the contact details provided.

The Center for Scientific Review is holding several closed meetings to review and evaluate grant applications. These meetings will take place virtually due to the confidential nature of the discussions, which could involve trade secrets and personal information. Four committees are involved, including the Molecular, Cellular, and Developmental Neuroscience Integrated Review Group and the Biological Chemistry and Macromolecular Biophysics Integrated Review Group, with meetings scheduled between March 25 and April 3, 2025. Each meeting will be led by a designated Scientific Review Officer from the National Institutes of Health.

The National Cancer Institute, part of the National Institutes of Health, is considering granting an exclusive patent license to Kyverna Therapeutics for technology involving chimeric antigen receptors (CARs) that target the CD19 protein. This technology is aimed at creating a treatment for autoimmune diseases using a patient’s own altered T lymphocytes. The license could cover worldwide territories and would allow Kyverna to develop, produce, and market this therapy. Public comments or objections about the patent license need to be submitted by March 5, 2021.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on March 19, 2021, from 11:30 a.m. to 2:00 p.m. The meeting is set to evaluate contract proposals and will be held virtually at the National Institutes of Health. It will remain closed to the public to protect confidential information, including trade secrets and personal data. Kelly L. Hudspeth, Ph.D., is the contact person for more details on the meeting.

The National Institute of Diabetes and Digestive and Kidney Diseases has announced a closed meeting on May 6, 2025, to review and evaluate grant applications. This meeting is closed to the public to protect confidential information and personal privacy. The meeting will be held virtually, with Lan Tian as the contact person for the event. The focus will be on assessing grant proposals related to urology and other relevant research areas.

The National Institutes of Health is holding two closed meetings to review grant applications as part of the Center for Scientific Review. These meetings will take place virtually, with the first on April 15-16, 2025, focusing on biophysical and neuroscience fellowships, and the second on April 24-25, 2025, focusing on imaging and bioengineering technology. The meetings are closed to protect confidential information and personal privacy related to the grant applications.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development announced a closed meeting set for March 28, 2025. This meeting will review and assess grant applications primarily focused on stillbirth prevention. The meeting will be held virtually, and information discussed will remain confidential to protect sensitive and personal information related to the applications. People who want more information can contact Dr. Luis E. Dettin at the NIH.